buprenorphine and naloxone
Generic: buprenorphine and naloxone
Labeler: bryant ranch prepackDrug Facts
Product Profile
Brand Name
buprenorphine and naloxone
Generic Name
buprenorphine and naloxone
Labeler
bryant ranch prepack
Dosage Form
TABLET
Routes
Active Ingredients
buprenorphine hydrochloride 2 mg/1, naloxone hydrochloride dihydrate .5 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
63629-9482
Product ID
63629-9482_56ec45bc-f40b-415f-874c-640a991faca9
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA205601
DEA Schedule
ciii
Listing Expiration
2026-12-31
Marketing Start
2020-04-13
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
636299482
Hyphenated Format
63629-9482
Supplemental Identifiers
RxCUI
UNII
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
buprenorphine and naloxone (source: ndc)
Generic Name
buprenorphine and naloxone (source: ndc)
Application Number
ANDA205601 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 2 mg/1
- .5 mg/1
Packaging
- 30 TABLET in 1 BOTTLE, PLASTIC (63629-9482-1)
Packages (1)
Ingredients (2)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["SUBLINGUAL"], "spl_id": "56ec45bc-f40b-415f-874c-640a991faca9", "openfda": {"unii": ["56W8MW3EN1", "5Q187997EE"], "rxcui": ["351266"], "spl_set_id": ["dd6e4fc9-a6f7-458a-b075-d736ce8b7172"], "manufacturer_name": ["Bryant Ranch Prepack"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE, PLASTIC (63629-9482-1)", "package_ndc": "63629-9482-1", "marketing_start_date": "20221212"}], "brand_name": "Buprenorphine and Naloxone", "product_id": "63629-9482_56ec45bc-f40b-415f-874c-640a991faca9", "dosage_form": "TABLET", "pharm_class": ["Opioid Antagonist [EPC]", "Opioid Antagonists [MoA]", "Partial Opioid Agonist [EPC]", "Partial Opioid Agonists [MoA]"], "product_ndc": "63629-9482", "dea_schedule": "CIII", "generic_name": "Buprenorphine and Naloxone", "labeler_name": "Bryant Ranch Prepack", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Buprenorphine and Naloxone", "active_ingredients": [{"name": "BUPRENORPHINE HYDROCHLORIDE", "strength": "2 mg/1"}, {"name": "NALOXONE HYDROCHLORIDE DIHYDRATE", "strength": ".5 mg/1"}], "application_number": "ANDA205601", "marketing_category": "ANDA", "marketing_start_date": "20200413", "listing_expiration_date": "20261231"}